President, North America Pharmaceuticals
2011 rank: 25
Connelly's division accounts for about one-third of GSK's revenue, but sales fell almost 5%, to just over $11 billion. Earlier this year she also became CEO of Human Genome Sciences, a
promising biotech firm that GSK acquired for $3 billion.